Atxn2 Protein (Ataxin 2) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Ataxin-2 (ATXN2) is a large RNA-binding protein implicated in RNA metabolism, stress granule formation, and translational control. Gain-of-function mutations and intermediate polyglutamine expansions in ATXN2 are associated with multiple neurodegenerative disorders, including Parkinson's disease, ALS, and frontotemporal dementia [1]. [1]
ATXN2 is a gene/protein encoding a key neuronal protein involved in synaptic function, signal transduction, and cellular homeostasis. Dysfunction of ATXN2 is associated with neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and related disorders. [2]
ATXN2 is a 1,313 amino acid protein with several functional domains: [3]
The polyQ tract length determines disease risk: [4]
ATXN2 participates in various RNA processing functions:
Under cellular stress, ATXN2 localizes to stress granules:
ATXN2 is involved in:
ATXN2 is one of the most important ALS risk genes:
| Approach | Stage | Notes |
|---|---|---|
| Antisense oligonucleotides | Preclinical | Targeting ATXN2 mRNA |
| Small molecule inhibitors | Discovery | Block polyQ aggregation |
| Stress granule modulators | Preclinical | Restore stress granule dynamics |
| RNA granule disruptors | Discovery | Target phase separation |
The study of Atxn2 Protein (Ataxin 2) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.